Abstract
The monography Immunology and Immunotherapy of Tumors provides a comprehensive overview of the processes and mechanisms that are important and why tumors escape from immunosurveillance. The second part of the monograph focuses on the currently available cancer immunotherapy and expected future developments, particularly in the field of immune checkpoint inhibitors and their combination with other anti-cancer treatment modalities.
The content of the monography has been developed by the collective effort of specialists in the fields of oncology, immunology and pathology for tumor development and growth, its control by the host immune system and reasons why tumors escape from the immunosurveillance. The second part of monography focuses on the currently available cancer immunotherapy and expected future developments, particularly in the area of the immune checkpoints' inhibitors and their combination with other anti-cancer treatment modalities.
Content of the monography has been developer by the collective effort of specialists in the fields of onkology, imunology and pathology.